INTRODuCTION
Tuberculosis is a transmissible airborne infection caused by Mycobacterium tuberculosis. It is transmitted by inhalation of infected droplet nuclei of 1-5 µm diameters that remain suspended in the environment when an infectious person coughs, sneezes, laughs or sings . 1 There were about 9 million new cases of tuberculosis in 2011 with 1.4 million deaths due to tuberculosis. The burden of tuberculosis is very high in our region, India and China combined accounting almost 40% of world cases. 2 Moreover, about 50% of world's multi-drug resistance tuberculosis (MDR-TB) cases are estimated to be in India and China.
3 With the advancement in diagnostic techniques it has been found that local epidemic of tuberculosis is mainly due to ongoing transmission rather than reactivation of dormant infection. Majority of transmission occurs before pulmonary tuberculosis is diagnosed and treated. Casual contact with infected environment may be sufficient for transmission. 4 The principal pathways leading to development of drugresistant tuberculosis are:
a. primary or initial and b. acquired or secondary.
Primary drug resistance means that a person has been infected with drug-resistant TB strain. The acquired drug resistance is mainly due to inappropriate case management. Inadequate, incomplete or poor treatment quality which allows growth of bacteria with resistant mutations and that ultimately become dominant strain. 5 There are different methods to test drug susceptibility-phenotypic or conventional drug sensitivity testing (DST) evaluates the growth or metabolic activity in the presence of the drug and genotypic DST (molecular DST) detects TB DNA and mutations associated with specific drug resistance.
5,6
The extent of drug resistant tuberculosis is difficult to estimate because culture sensitivity is not a routine test especially in newly diagnosed cases due to inadequate number of quality controlled laboratories in Nepal. This study is an effort to find out the prevalence of primary drug resistance in newly diagnosed tuberculosis patients serving in the Nepalese Armed Forces.
MATeRIAlS AND MeTHODS
This retrospective study was done in the Department of Chest Diseases of Shree Birendra Hospital, Chhauni, Kathmandu. Medical records of 134 serving soldiers of the Nepalese Armed Forces admitted with the provisional diagnosis of pulmonary tuberculosis from July 2012 to June 2014 were analyzed. All the patients had their three samples of sputum (including two of early morning sputum) examined and culture and sensitivity done for acid and alcohol fast bacilli (AFB) in German Nepal Tuberculosis Project (GENETUP) laboratory. The GENETUP is accredited as the National Reference Laboratory by Supranational Reference Laboratory, Gauting, Germany for culture and drug sensitivity test for tuberculosis.
All sputum samples were examined by Ziehl-Neelsen method for AFB. Sputum samples were decontaminated with NACNaOH method and cultured in Lowenstein Jensen media for 8 weeks. The positive growth was identified by using paraminobenzoic acid. Drug susceptibility testing (DST) was performed by conventional 1 per cent proportion method against streptomycin (4µg/ml), isoniazid (0.2µg/ml), rifampicin (40µg/ml) and ethambutol (2µg /ml).
ReSulTS
Out of 134 patients, 62 patients had culture positive for Mycobacteria tuberculosis. Of them 2 cases were smear negative. All 62 patients in this study were young. Of them 24 patients (39%) were in the age group 25-29 followed by 16 patients (26 %) in age group 30-34 years. (Table 1 ) 22 37 Drug resistant strains were found in 5 cases (8.1%) of which 2 (3.322%) were resistant to all 4 drugs-rifampicin, isoniazid, ethambutol and streptomycin. Two drugs resistant cases were 2 (3.2%), one case resistant to rifampicin and isoniazid and another one to isoniazid and streptomycin. Single drug (ethambutol) resistance was found in a patient (1.6%). MDR resistant cases were 4.8%. (Table 3 ) Two smear negative cases were culture positive for MTB and strains were susceptible to first four drugs. It was seen that isoniazid resistance was highest with 3 cases (4.8%). Strains resistant to rifampicin were found in 3.2 % cases.
All the drug resistant cases were smear negative at the time of writing this paper except one who was tested positive for HIV and second line drug therapy was recently started.
DISCuSSION
Emergence of drug resistance strain of Mycobacterium tuberculosis due to the genetic mutation in the bacilli is a major challenge for the Millennium Development Goals (MDG).
5
WHO estimation of MDR-TB burden in new cases for Nepal and India for 2013 was 2.2% which was lower than our findings though we had smaller sample size. China has reported that 5.7% were MDR-TB among new cases in her national survey. Former Soviet Union region has top 10 locations for primary MDR tuberculosis. Of them Kyrgyzstan has the highest (26%). Two surveys were carried out in Nepal by National Tuberculosis Program (NTP) and GENETUP in 2010 for primary drug resistance tuberculosis. The prevalence of MDR-TB in new cases was same on both surveys (2.2% The prevalence of primary drug resistant tuberculosis of 8.1% in our study was lower than reported in two studies from North India. The prevalence of 4 drugs resistant strain and the strain resistant to isoniazid and other three drugs were higher in their studies. 10, 11 Isoniazid resistance without rifampicin resistance in new cases was lower in our study than Global estimation. 3 Isoniazid resistance has been reported 41% in a study by Maurya A K et al. 9 Study by Malhotra B et al from Jaipur, India found that primary drug resistance to isoniazid was 13.6%, and to rifampicin 6.8%, both were higher than our findings. 10 Resistance to isoniazid and rifampicin in previously treated patients was much higher-62.22% and 57.22% respectively. 13, 14 Abouyannis M et al in their study in Malawi found only 0.4% of the 1196 new cases were MDR-TB and mono-drug resistance or any combination of drug resistance excluding MDR cases were 6.3%. They have attributed the success to Malawi's tuberculosis programme.
15
Difference of prevalence of drug resistance among countries may be due to difference in the use of antituberculosis drugs and their combinations and use of these drugs to treat other bacterial infections and effectiveness of national programme.
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CONCluSION
Primary drug resistant tuberculosis in newly diagnosed cases was quite common even in young healthy adults of the Nepalese Armed Forces. Isoniazid resistant strains were the commonest.
